The future of infectious disease diagnostics starts at Day Zero. By using whole-genome sequencing (WGS) and the proprietary enabling technologies, Day Zero is creating a new class of sequencing-based in-vitro diagnostics that generates clinically actionable data at scale.

Medical Devices

Day Zero Diagnostics

Jong Lee

Manoj Nair

Melis Anahtar, MD, PhD

Melodie Domurad

Dougal Maclaurin

Melis Anahtar

Doug Kwon

Rene Robert

Dekel Gelbman

Miriam Huntley

Day Zero Diagnostics' Leadership Team includes Matt Turner and 16 others.

Leadership Team

Leadership Team

About

Team members